Intellia Therapeutics
NTLAIntellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Nova …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Intellia Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/29/2025 | Sell | Bhanji, Muna | Director | $8.5 | $2,253 |
| 3/4/2025 | Sell | Basta, James | EVP, General Counsel | $9.0 | $23,122 |
| 3/4/2025 | Sell | Clark, Eliana | EVP, Chief Technical Officer | $9.0 | $6,104 |
| 1/29/2025 | Sell | Bhanji, Muna | Director | $10.0 | $2,642 |
| 1/3/2025 | Sell | Clark, Eliana | EVP, Chief Technical Officer | $12.2 | $90,400 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)